Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y.
Journal of Rheumatology 34(9): 1944-1945
2007
ISSN/ISBN: 0315-162X PMID: 17787055 Document Number: 613831
Document emailed within 1 workday
Related Documents
Girelli, F.; Foschi, F.G.; Bedeschi, E.; Calderoni, V.; Stefanini, G.F.; Martinelli, M.G. 2004: Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? European Annals of Allergy and Clinical Immunology 36(4): 127-130Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Hayashi, N.; Kumagai, S. 2010: Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 466-479
Barcelos, F.; Abreu, I.; Patto, J.é V.; Trindade, H.él.; Teixeira, A. 2009: Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome Acta Reumatologica Portuguesa 34(4): 608-612
Lequerré, T.; Richez, C. 2012: Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis La Revue du Praticien 62(8): 1088-1089
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Feltkamp, T.E.; Berthelot, J.M.; Boerbooms, A.M.; Geertzen, H.G.; Hoet, R.; De Keyser, F.; van Venrooij, W.J.; Verbruggen, G.; Veys, E.M.; Youinou, P. 1993: Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis Clinical and Experimental Rheumatology 11(1): 57-59
Ramírez, Súl.; Ramírez, Mía.G.; Muñoz, Jé.F.; Martínez, G.E.; Velarde, E.E.; Sánchez, P.E. 2019: Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis Medicina 79(3): 161-166
Bobbio-Pallavicini, F.; Caporali, R.; Bugatti, S.; Montecucco, C. 2008: What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies? Journal of Rheumatology 35(10): 1903-1905
Yalaoui, S. 2006: Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis Archives de l'Institut Pasteur de Tunis 83(1-4): 13-17
Toes, R.E.; van der Woude, D. 2011: ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis Acta Reumatologica Portuguesa 36(3): 205-207
Youinou, P.; Le Goff, P.; Miossec, P.; Moineau, M.P.; Ferec, C. 1983: Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis Zeitschrift für Rheumatologie 42(1): 36-39
Hayashi, S.; Kiyokawa, T.; Aochi, H.; Nagamine, K.; Oshida, M.; Tomiyama, Y.; Kurata, Y. 1994: Detection of anti-neutrophil antibodies by enzyme linked immunosorbent assay--comparison of results obtained by ELISA with those by leukocyte agglutination test and granulocyte cytotoxicity test Rinsho Byori. Japanese Journal of Clinical Pathology 42(5): 527-533
Rezuş, E.; Grigoriu, A.; Rezuş, C. 2009: Aggressive nature of rheumatic arthritis with citrullinated cyclic peptide antibodies Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 73-78
Muñoz-Fernãndez, S.; Alvarez-Doforno, R.; Fontán, G.; Gijón, J. 1995: Antiperinuclear factor isotypes in rheumatoid arthritis Clinical and Experimental Rheumatology 13(4): 529; Author Reply 530-1
Jansen, T.L.T.A.; Bruyn, G.A.W. 2004: Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis Journal of rheumatology 31(5): 1012-3; author reply 1013
Grieble, H.; Bach, G.; Anderson, T.; Zschocke, R. 1971: Standardization of the latex fixation test for the demonstration of the rheumatoid factor. 3. Nature of the rheumatoid factor in normal serum, in serum of patients with rheumatoid arthritis, and in serum of the aged Acta Biologica et Medica Germanica 26(1): 185-191